These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 28926138)
1. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer. Han Y; Tang Z; Zhao Y; Li Q; Wang E Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138 [TBL] [Abstract][Full Text] [Related]
2. TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma. Dong Q; Fu L; Zhao Y; Xie C; Li Q; Wang E Oncotarget; 2017 Feb; 8(9):15689-15703. PubMed ID: 28152516 [TBL] [Abstract][Full Text] [Related]
3. m Wu J; Yi T; Zhuo C; Wang D; Zhang M; Hu R; Wu D; Hou G; Xing Y J Cell Physiol; 2024 May; 239(5):e31220. PubMed ID: 38372068 [TBL] [Abstract][Full Text] [Related]
4. LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling. Cheng Y; Hou T; Ping J; Chen T; Yin B J Exp Clin Cancer Res; 2018 Sep; 37(1):228. PubMed ID: 30219064 [TBL] [Abstract][Full Text] [Related]
5. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis. Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988 [TBL] [Abstract][Full Text] [Related]
6. 17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway. Ye XY; Luo QQ; Xu YH; Tang NW; Niu XM; Li ZM; Shen SP; Lu S; Chen ZW J Cell Mol Med; 2015 Mar; 19(3):651-63. PubMed ID: 25712415 [TBL] [Abstract][Full Text] [Related]
7. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2. Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938 [No Abstract] [Full Text] [Related]
8. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3. Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596 [TBL] [Abstract][Full Text] [Related]
9. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway. Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569 [TBL] [Abstract][Full Text] [Related]
10. Hippo signaling promotes JNK-dependent cell migration. Ma X; Wang H; Ji J; Xu W; Sun Y; Li W; Zhang X; Chen J; Xue L Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1934-1939. PubMed ID: 28174264 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells. You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359 [TBL] [Abstract][Full Text] [Related]
12. Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer. Dong Q; Fu L; Zhao Y; Du Y; Li Q; Qiu X; Wang E Oncotarget; 2017 Apr; 8(17):27800-27811. PubMed ID: 28468127 [TBL] [Abstract][Full Text] [Related]
13. LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway. Zhang M; Zhao Y; Zhang Y; Wang D; Gu S; Feng W; Peng W; Gong A; Xu M Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1770-1782. PubMed ID: 29510195 [TBL] [Abstract][Full Text] [Related]
14. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1. Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671 [TBL] [Abstract][Full Text] [Related]
15. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling. Zhou Y; Shan T; Ding W; Hua Z; Shen Y; Lu Z; Chen B; Dai T J Cell Physiol; 2018 Aug; 233(8):5805-5814. PubMed ID: 29215734 [TBL] [Abstract][Full Text] [Related]
16. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma. Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036 [TBL] [Abstract][Full Text] [Related]
17. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP. Thines L; Gorisse L; Li Z; Sayedyahossein S; Sacks DB J Biol Chem; 2022 May; 298(5):101839. PubMed ID: 35307353 [TBL] [Abstract][Full Text] [Related]
18. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis. Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750 [TBL] [Abstract][Full Text] [Related]
19. Circular RNA circ_0067741 regulates the Hippo/YAP pathway to suppress lung adenocarcinoma progression by targeting microRNA-183-5p. Mo J; Nie H; Zeng C; Han H; Xu P; Shi X Bioengineered; 2022 Apr; 13(4):10165-10176. PubMed ID: 35435136 [TBL] [Abstract][Full Text] [Related]
20. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling. Mana-Capelli S; McCollum D J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]